Related Experiment Video
Updated: May 5, 2026
Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
Published on: January 12, 2022
Severe retinopathy induced by low-dose tamoxifen: a 10-month follow-up analysis based on multimodal imaging
Shaochi Zhang1, Yuanru Wang2, Yang Liu3
1People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, Ningxia, China. 386309545@qq.com.
Background:
Tamoxifen retinopathy (TAM-R) typically occurs with prolonged and high-dose administration. This study presents an uncommon instance of severe TAM-R following 3.75 years of low-dose tamoxifen (10 mg/day) treatment, totaling 450 mg cumulatively.
Case Report:
A 35-year-old female with obesity (BMI 47.86 kg/m²) presented with bilateral vision loss. Multimodal imaging (OCT/OCTA/FFA/FAF) revealed retinal crystal deposition, macular pseudocyst, ellipsoid layer rupture, and deep capillary plexus loss. Despite discontinuation of medication, visual acuity remained poor (BCVA of 20/125 in the right eye and 20/667 in the left eye). At the 10-month follow-up, there was partial structural improvement, yet ellipsoid layer impairment persisted.
Conclusion:
This case challenges traditional TAM-R dosage thresholds, suggesting obesity may exacerbate toxicity. Baseline OCTA vascular markers correlate with irreversible visual impairment, offering novel insights for prognostic evaluation.
